Obesity News

Community health workers can reduce hospital visits by helping patients better manage diabetes, lower their BP and cholesterol, and stay up to date on cancer screenings, a speaker at the Annual Rural Health Conference said.

The FDA announced it approved the injectable dual incretin agonist tirzepatide to improve glucose response in adults with type 2 diabetes in addition to diet and exercise.

The FDA recently halted a clinical trial evaluating an investigational stem cell-derived therapy for people with type 1 diabetes with impaired hypoglycemia awareness and severe hypoglycemia.

CHICAGO — In this video, Healio Primary Care Peer Perspective Board Member Alan Dow, MD, MSHA, FACP, reviews highlights from various presentations that he attended during the ACP Internal Medicine Meeting.

Multicomponent exercise interventions were associated with greater improvements in measures of cardiometabolic health in people with overweight or obesity vs. single-component exercise interventions, according to a meta-analysis.

CHICAGO — In this video, Carol Ewing Garber, PhD, FAHA, FACSM, FNAK, discusses how to get patients to “move more and sit less.”

CHICAGO — In this video, Adrienne Youdim, MD, FACP, discusses the social factors driving the rising prevalence of obesity in the United States.

Topline data from the SURMOUNT-1 trial showed that once-weekly treatment with tirzepatide reduced weight among adults with overweight or obesity.

CHICAGO — Food choices are some of the most important choices a person can make for their health, Michelle McMacken, MD, FACP, DipABLM, said during a presentation at the ACP Internal Medicine Meeting.

CHICAGO — In this video, Sheila Tsai, MD, a sleep medicine physician at National Jewish Health in Denver, discusses how to screen, diagnose and treat obstructive sleep apnea and obesity hypoventilation syndrome.